Oh good, we're still citing a paper from *checks notes* 2012, and ignoring that in the subsequent 13 years over 1200 patients have been treated with iPSC derived MSCs, over 25% at Cynata alone, and tumorigenisis has not been a reported event.
Ann: Publication comparing Cymerus MSCs to other MSCs, page-47
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $36.15M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $58.52K | 355.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 613829 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 14285 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |